Compare CLPS & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLPS | SCNX |
|---|---|---|
| Founded | 2005 | 2010 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Other Pharmaceuticals |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.8M | 31.5M |
| IPO Year | 2018 | 2020 |
| Metric | CLPS | SCNX |
|---|---|---|
| Price | $0.93 | $0.59 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 26.3K | ★ 16.2M |
| Earning Date | 10-17-2025 | 11-13-2025 |
| Dividend Yield | ★ 14.21% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $164,481,414.00 | $653,391.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 15.17 | ★ 207.88 |
| 52 Week Low | $0.82 | $0.46 |
| 52 Week High | $1.88 | $8.72 |
| Indicator | CLPS | SCNX |
|---|---|---|
| Relative Strength Index (RSI) | 49.98 | 44.37 |
| Support Level | $0.90 | $0.58 |
| Resistance Level | $0.98 | $0.62 |
| Average True Range (ATR) | 0.07 | 0.06 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 46.94 | 34.03 |
CLPS Inc. is an IT consulting and solutions provider serving international clients in the banking, wealth management, e-commerce, and automotive sectors. The company drives digital transformation using AI, cloud computing, and big data, offering IT consulting, customized solutions, virtual banking training, recruitment, professional training, and software services. It operates mainly in two segments: IT services, which generate the majority of its revenue, and academic education services. The company has a presence in Hong Kong, Singapore, Mainland China, India, Malaysia, and Japan, with the majority of its revenue coming from Mainland China.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.